Corpus Intelligence EBITDA Bridge — MACON COUNTY GENERAL HOSPITAL 2026-04-26 23:27 UTC
EBITDA Bridge — MACON COUNTY GENERAL HOSPITAL
CCN 441305 | TN | 25 beds | Current EBITDA $-79K → Pro Forma $904K (+$982K)
🛡️ Public data only — no PHI permitted on this instance.
EBITDA BRIDGE  ·  CCN 441305

MACON COUNTY GENERAL HOSPITAL
value-creation walk.

7-lever RCM bridge from current EBITDA to pro-forma — denial / underpay / DAR / coding / contract / cost discipline / cash acceleration. Each lever shows current vs benchmark target with data provenance.

$18.7M
Net Revenue HCRIS
$-79K
Current EBITDA COMPUTED
+$982K
RCM EBITDA Uplift
$904K
Pro Forma EBITDA
+526bps
Margin Improvement
$716K
WC Released (1x)

Bridge Realization Estimate

ML model predicts what fraction of the bridge is achievable (accuracy: 60%, n=5,839)

65%
Realization (C)
$982K
Modeled Uplift
$637K
Risk-Adjusted
-$345K
Execution Discount
Occupancy RateLower Occupancy Rate reduces execution likelihood
Revenue per BedLower Revenue per Bed reduces execution likelihood
Bed CountHigher Bed Count increases execution likelihood
Commercial Payer %Higher Commercial Payer % increases execution like
Payer DiversityPayer Diversity has minimal effect on execution

Expected realization: 65% of modeled bridge. Strengths: Bed Count, Commercial Payer %. Risks: Occupancy Rate, Revenue per Bed. Risk-adjusted uplift: $0.6M (vs $1.0M modeled).

EBITDA Bridge — 7 RCM Levers

Each bar shows the annual EBITDA impact at full run-rate. Revenue levers increase top-line; cost levers reduce operating expense; cash acceleration releases working capital. Calibrated to published research bands (Denial 12%→5% = $8-15M on $400M NPR).

Cost to Collect
Cost Savings | 12mo ramp
$373K
+200bp
Denial Rate Reduction
Revenue | 12mo ramp
$370K
+198bp
A/R Days Reduction
Cash Accel | 9mo ramp
$227K
+122bp
Clean Claim Rate
Cost Savings | 6mo ramp
$12K
+6bp
Total EBITDA Impact$982K

Lever Detail

Each value shows its data source. SELLER = seller data room, DEFAULT = model default, BENCHMARK = P75 peer benchmark.

LeverCurrentTargetRevenueCostEBITDAWCRamp
Cost to Collect4.5% DEFAULT2.5% BENCHMARK$0$373K$373K$012mo
Denial Rate Reduction12.0% DEFAULT6.5% BENCHMARK$359K$10K$370K$012mo
A/R Days Reduction52.00 DEFAULT38.00 BENCHMARK$57K$170K$227K$716K9mo
Clean Claim Rate88.0% DEFAULT96.0% BENCHMARK$0$12K$12K$06mo
Net Collection Rate93.5% DEFAULT45.7% BENCHMARK$0$0$0$018mo
CDI / Case Mix Index135.0% DEFAULT142.0% BENCHMARK$0$0$0$018mo

Implementation Timing Curve

Linear ramp to full run-rate per lever. Month 0 = close date. Partners should expect 60-70% of total uplift realized by month 12.

LeverM0M3M6M9M12M18M24M36
Cost to Collect$0$93K$187K$280K$373K$373K$373K$373K
Denial Rate Reduction$0$92K$185K$277K$370K$370K$370K$370K
A/R Days Reduction$0$76K$151K$227K$227K$227K$227K$227K
Clean Claim Rate$0$6K$12K$12K$12K$12K$12K$12K
Cumulative$0$267K$535K$796K$982K$982K$982K$982K

Returns Sensitivity (IRR / MOIC)

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Green = exceeds 20% IRR hurdle. Amber = 15-20%. Red = below hurdle or loss. RCM uplift of $982K is added at exit.

Entry \ Exit9.0x10.0x11.0x11.5x12.0x
8.0x-100% / 0.0x-100% / 0.0x-100% / 0.0x-100% / 0.0x-100% / 0.0x
9.0x-100% / 0.0x-100% / 0.0x-100% / 0.0x-100% / 0.0x-100% / 0.0x
10.0x-100% / 0.0x-100% / 0.0x-100% / 0.0x-100% / 0.0x-100% / 0.0x
11.0x-100% / 0.0x-100% / 0.0x-100% / 0.0x-100% / 0.0x-100% / 0.0x
12.0x-100% / 0.0x-100% / 0.0x-100% / 0.0x-100% / 0.0x-100% / 0.0x

Covenant Headroom (at 10x Entry, 6.5x Max Leverage)

99.0x
Entry Leverage
-0.7x
Pro Forma Leverage
7.2x
Headroom (turns)
111%
EBITDA Cushion

Pro forma EBITDA can decline 111% before the 6.5x covenant trips. RCM uplift reduces leverage from 99.0x to -0.7x, adding 99.7 turns of cushion.

5-Year Value Creation Waterfall

EBITDA trajectory: 3% organic growth + RCM uplift ramp (full run-rate at month 18).

Base EBITDARCM UpliftTotalMargin
Entry$-79K$-79K-0.4%
Year 1$-81K+$655K$574K3.1%
Year 2$-83K+$982K$899K4.8%
Year 3$-86K+$982K$896K4.8%
Year 4$-89K+$982K$894K4.8%
Year 5$-91K+$982K$891K4.8%
$-786K
Entry EV (10x)
$9.8M
Exit EV (11x)
$10.6M
Value Created
$891K
Exit EBITDA
$-125K
Organic Growth
$9.8M
RCM Value Creation
$891K
Multiple Expansion

Achievement Sensitivity

What if we only achieve a fraction of each lever? 50% = conservative, 75% = base management case, 100% = plan, 120% = stretch.

Lever50%75%100%120%
Cost to Collect$187K$280K$373K$448K
Denial Rate Reductio$185K$277K$370K$444K
A/R Days Reduction$114K$170K$227K$273K
Clean Claim Rate$6K$9K$12K$14K
Total$491K$737K$982K$1.2M

Peer Context — Where This Hospital Sits

Key metrics vs 56 size-matched peers. Low percentile on margin/efficiency metrics = more room for improvement = larger bridge opportunity.

MetricHospitalP25P50P75Percentile
Op Margin-0.4%-14.0%-0.8%9.2%
P53
Net-to-Gross34.0%20.2%29.8%45.7%
P59
Occupancy37.1%21.2%35.4%69.7%
P51
Rev/Bed$747K$401K$536K$950K
P70
Exp/Bed$750K$355K$573K$1.0M
P59

Bridge Methodology

Coefficients calibrated to published research bands: denial 12%→5% = $8-15M on $400M NPR. Current metrics estimated from HCRIS public data and ML predictions. Target metrics set at P75 peer benchmarks with 60% gap closure assumption. Revenue levers use NPR × delta × avoidable share. Cost levers use claims volume × cost per reworked claim. Working capital from AR reduction is one-time cash (not included in recurring EBITDA). Returns assume 5.5x leverage, 3% organic growth, 10%/yr debt paydown.

Data: HCRIS FY2022 | 6,123 hospitalsSources: HCRISML